Can J Kidney Health Dis. 2015 May 11;2:21. doi: 10.1186/s40697-015-0052-y. eCollection 2015.
PTHrP-related Hypercalcaemia in Infancy and Congenital Anomalies of the Kidney and Urinary Tract (CAKUT).
Canadian journal of kidney health and disease
Nardeen Kodous, Guido Filler, Ajay Parkash Sharma, Tamara Angela Van Hooren
Affiliations
Affiliations
- Department of Paediatrics, Division of Nephrology, University of Western Ontario, 800 Commissioners Road East, Rm B1-436, London, ON N6A 5 W9 Canada.
- Department of Paediatrics, Division of General Paediatrics, University of Western Ontario, London, ON Canada.
PMID: 26019888
PMCID: PMC4445997 DOI: 10.1186/s40697-015-0052-y
Abstract
BACKGROUND: Severe hypercalcaemia is a rare but clinically significant condition in infancy and childhood. Parathyroid hormone-related peptide (PTHrP)-mediated hypercalcaemia resulting from a malignancy is rare and only a handful of case reports have outlined its incidence alongside a benign condition.
OBJECTIVES: To describe the diagnostic workup and management of an infant with hypercalcaemia, renal dysplasia, and elevated PTHrP levels.
DESIGN: Case report.
SETTING: The Victoria Hospital campus of the London Health Sciences Centre in London, Ontario, Canada.
PATIENTS: A child with congenital anomalies of the kidneys and urinary tract (CAKUT), stage 2 chronic kidney disease (CKD), and renal dysplasia who presented with severe hypercalcaemia.
MEASUREMENTS: Weight, renal ultrasound, creatinine, cystatin C, eGFR, calcium, urea, bicarbonate, serum sodium, fractional sodium excretion, urine calcium to creatinine ratio, PTH, TSH, Free T4, AM cortisol, HMA, VMA, 25-vitamin D, 1,25 dihydroxy-vitamin D, calcitriol, vitamin A, ACE levels, skull and chest x-rays, alkaline phosphatase, CBC, tumour lysis profile, catecholamine breakdown, whole-body MRI, PTHrP.
METHODS: Full diagnostic workup and patient management. Patient treated with intravenous hydration, furosemide, calcitonin and CalciLo.
RESULTS: PTHrP was elevated and no evidence of a malignancy was found. Treatment consisting of a low-calcium CalciLo diet (in place of breast milk) adequately controlled the patient's hypercalcaemia. Hypercalcaemia associated with CAKUT in infancy is not all that uncommon and was reported in 15/99 infants in another study, most of whom had a suppressed PTH similar to that of our patient. PTHrP was not measured in these cases and may have also been elevated.
LIMITATIONS: The study is limited in that it is a description of a single patient case. Future measurement of PTHrP in similar patients is necessary to confirm our results.
CONCLUSIONS: The possibility of elevated PTHrP levels must be considered in patients with known renal dysplasia who are differentially diagnosed with hypercalcaemia.
Keywords: Chronic kidney disease; Failure to thrive; Hypercalcemia; Infant; Treatment
References
- Am J Nephrol. 2001 May-Jun;21(3):179-84 - PubMed
- J Pediatr Endocrinol Metab. 2013;26(3-4):365-7 - PubMed
- QJM. 2008 Apr;101(4):329-30 - PubMed
- Curr Opin Pediatr. 2010 Aug;22(4):508-15 - PubMed
- J Bone Miner Res. 2013 Feb;28(2):419-30 - PubMed
- Pediatr Nephrol. 2011 May;26(5):799-803 - PubMed
- Am J Med Sci. 2008 May;335(5):407-8 - PubMed
- Pediatr Nephrol. 2003 Oct;18(10 ):981-5 - PubMed
- Ann Nucl Med. 1994 Nov;8(4):231-7 - PubMed
- Kidney Int. 2013 May;83(5):777-9 - PubMed
- Clin Nephrol. 2011 May;75(5):466-71 - PubMed
- Science. 1987 Aug 21;237(4817):893-6 - PubMed
- Pediatr Transplant. 2011 Feb;15(1):25-31 - PubMed
- Arch Dis Child. 1986 Jul;61(7):677-81 - PubMed
- J Pediatr. 2014 May;164(5):1026-1031.e2 - PubMed
- Proc Natl Acad Sci U S A. 1989 Apr;86(7):2408-12 - PubMed
- Am J Clin Pathol. 1996 Apr;105(4):487-92 - PubMed
- Arch Dis Child Fetal Neonatal Ed. 2014 Sep;99(5):F419-21 - PubMed
- N Engl J Med. 2000 Jan 20;342(3):177-85 - PubMed
Publication Types